e-Learning About Cognitive Impairment and Dementia Prevention
NCT ID: NCT05383118
Last Updated: 2023-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
536 participants
INTERVENTIONAL
2023-03-27
2023-08-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this phase is to explore if and how our dementia prevention e-learning influences participants' knowledge, intentions and health behaviours related to dementia risk.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dementia Prevention Internet-Based Intervention: Randomized Controlled Trial and Knowledge Translation
NCT06911047
An Internet-Based Education Program for Care Partners of People Living With Dementia
NCT05114187
Community-based Brain Health Program to Address Dementia Risk
NCT05529706
Intervention on Modifiable Lifestyle Risk Factors for Dementia Prevention
NCT04616794
Implementation Study of Dementia Guidelines in Primary Care
NCT00459784
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
With our aging population, the prevalence of dementia is increasing dramatically. Developing a better understanding of how dementia can be prevented and sharing information about how Canadians can reduce their risk of developing dementia or delay its onset is critical to keeping Canadians healthy and improving quality of life. Web-based interventions in dementia have been shown to be effective for a range of outcomes, but very few have been widely implemented or rigorously studied; additionally, national, and provincial guidelines have all highlighted the importance of online resources to improve dementia prevention education. This has been further brought into focus by the coronavirus pandemic. While there have been studies of web-based health information on intentions and behaviour change, the vast majority of those studies have looked at text-based health information, rather than internet-based interventions that have incorporated best practices in instructional design for e-learning. This project will help to address this gap in the literature, as improved instructional design should have an impact on knowledge gain, which the investigators hypothesize may increase intentions and behaviour change.
The investigators developed a high-quality, award-winning web- and email-based dementia prevention education platform for care partners, which includes asynchronous, multimedia e-learning lessons and email-based 'micro-learning' content to reinforce the learning.
Objective:
In this proposal, the investigators plan to study the effectiveness of our web-based intervention on dementia prevention knowledge, intentions, and behaviour change.
Methods:
Design, Setting, and Participants:
This study is a sequential explanatory mixed methods design randomized controlled trial. Following eligibility screening, informed consent, and baseline socio-demographic measures, participants will be randomized either to the intervention group or the control group. Those adults (age ≥ 16) who have no prior diagnosis of dementia, have internet and email access, and are fluent in English will be eligible to participate. Participants will be randomized and directed to their assigned learning path after submitting online informed consent and baseline measures using the Division of e-Learning Innovation's research platform. Participants will be randomized using a block randomization. To the best of our ability, efforts will be made to blind participants to their allocation group and study hypotheses.
Intervention:
Participants randomized to the intervention group will receive the dementia prevention e-learning. Participants in the control group will be assigned an alternate-topic e-learning lesson. All participants will be given access to all e-learning at the conclusion of the study.
Outcomes:
The purpose of this phase is to explore if and how our dementia prevention e-learning influences participants' knowledge, intentions and health behaviours related to dementia risk.
The specific aims are:
1. To evaluate whether exposure to the e-learning intervention changes knowledge of dementia risk factors, intention to engage in risk reduction activities, and health behaviours related to dementia prevention.
2. To explore qualitative aspects such as participants' engagement and satisfaction with the intervention, as well as barriers and facilitators to use, through surveys and synchronous online focus groups.
Implications and Relevance:
The results of this study will contribute to the planning of a larger randomized controlled trial (RCT) in the future; as well as the evaluation of innovative, cost-effective, and efficient dementia prevention resources that can complement traditional approaches. The intervention could be easily scaled and spread to complement other dementia education methods.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Education Intervention
Participants in the intervention group will be provided e-learning about dementia prevention and promoting brain health, consisting of following components:
1. One multimedia e-learning lesson on promoting brain health and preventing dementia;
2. A series of 12 'micro-learning' emails (3 emails/week) with small segments of content to reinforce the material from the lesson.
3. Curated resources related to dementia risk factors
Education Intervention
Participants in the intervention group will be provided e-learning about dementia prevention and promoting brain health, consisting of following components:
1. One multimedia e-learning lesson on promoting brain health and preventing dementia;
2. A series of 12 'micro-learning' emails (3 emails/week) with small segments of content to reinforce the material from the lesson.
3. Curated resources related to dementia risk factors
Education Control
Participants in the control group will be provided e-learning about mild cognitive impairment, consisting of following components:
1. One multimedia e-learning lesson on mild cognitive impairment;
2. A series of 12 'micro-learning' emails (3 emails/week) with small segments of content to reinforce the material from the lesson.
3. Curated resources related to mild cognitive impairment
Education Control
Participants in the control group will be provided e-learning about mild cognitive impairment, consisting of following components:
1. One multimedia e-learning lesson on mild cognitive impairment;
2. A series of 12 'micro-learning' emails (3 emails/week) with small segments of content to reinforce the material from the lesson.
3. Curated resources related to mild cognitive impairment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education Intervention
Participants in the intervention group will be provided e-learning about dementia prevention and promoting brain health, consisting of following components:
1. One multimedia e-learning lesson on promoting brain health and preventing dementia;
2. A series of 12 'micro-learning' emails (3 emails/week) with small segments of content to reinforce the material from the lesson.
3. Curated resources related to dementia risk factors
Education Control
Participants in the control group will be provided e-learning about mild cognitive impairment, consisting of following components:
1. One multimedia e-learning lesson on mild cognitive impairment;
2. A series of 12 'micro-learning' emails (3 emails/week) with small segments of content to reinforce the material from the lesson.
3. Curated resources related to mild cognitive impairment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Live in Canada
* 16 years of age and over
* Good command of the English language
* Access to email and internet
* Comfortable using email and internet, and
* Ability to grant online informed consent
Exclusion Criteria
* Lives outside of Canada
* Not 16 years of age or over
* Does not speak English,
* Does not have access to email or internet
* Is not comfortable using email of internet
* Does not grant informed consent
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Public Health Agency of Canada (PHAC)
OTHER_GOV
McMaster University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McMaster University
Hamilton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Levinson AJ, Ayers S, Clark S, Woodburn R, Dobbins M, Duarte D, Grad R, Kates N, Marr S, Oliver D, Papaioannou A, Saperson K, Siu H, Strudwick G, Sztramko R, Neil-Sztramko S. Internet-Based Dementia Prevention Intervention (DementiaRisk): Protocol for a Randomized Controlled Trial and Knowledge Translation. JMIR Res Protoc. 2025 Jan 27;14:e64718. doi: 10.2196/64718.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Levinson_ISFR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.